Cited by 406Peripheral Artery Disease ManagementLipoproteins and Cardiovascular HealthVascular Procedures and Complications

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Open access

Pande, Reena L., Perlstein, Todd S., Beckman, Joshua A., Creager, Mark A.·2011·Circulation

DOI 10.1161/circulationaha.110.003954PMC PMC3139992

Open this paper in CoChat — free account

Abstract

Background—: Whether individuals with peripheral artery disease (PAD) identified by screening ankle-brachial index benefit from preventive therapies to reduce cardiovascular risk is unknown. We aimed to determine the number of US adults with PAD who are not receiving preventive therapies and whether treatment is associated with reduced mortality in PAD subjects without known cardiovascular disease. Methods and Results—: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004 with mortality follow-up through December 31, 2006. We defined PAD as an ankle-brachial index ≤0.90. Of 7458 eligible participants ≥40 years, weighted PAD prevalence was 5.9±0.3% (mean±SE), corresponding to ≈7.1 million US adults with PAD. Statin use was reported in only 30.5±2.5%, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use in 24.9±1.9%, and aspirin use in 35.8±2.9%, corresponding to 5.0 million adults with PAD not taking statins, 5.4 million not taking angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and 4.5 million not receiving aspirin. After adjustment for age, sex, and race/ethnicity, PAD was associated with all-cause mortality (hazard ratio, 2.4; 95% confidence interval, 1.9 to 2.9; P <0.0001). Even after exclusion of individuals with known cardiovascular disease, subjects with PAD had higher mortality rates (16.1±2.1%) than subjects without PAD or cardiovascular disease (4.1±0.3%), with an adjusted hazard ratio of 1.9 (95% confidence interval, 1.3 to 2.8; P =0.001). Among PAD subjects without cardiovascular disease, use of multiple preventive therapies was associated with 65% lower all-cause mortality (hazard ratio, 0.35; 95% confidence interval, 0.20 to 0.86; P =0.02). Conclusions—: Millions of US adults with PAD are not receiving secondary prevention therapies. Treatment with multiple therapies is associated with reduced all-cause mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.003954

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Self-citation
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,098

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 301–400 of 406

Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease
Naazie, I. N., Arhuidese, I. J., Abdelgawwad, M. S., Unkart, J., Conte, M. S., & Malas, M. B. (2022) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.07.022 · Cited by 2
Endovascular Revascularization and Outcomes of Critical Limb-Threatening Ischemia in Trinidad and Tobago: The EVENT Pilot Study—Challenges in a Limited-Resource, Caribbean Setting
Harnanan, D., Parbhu, S., Pran, L., Baboolal, I., Harnarayan, P., Naraynsingh, V., & Seecheran, N. A. (2023) · Cardiology and Therapy · doi:10.1007/s40119-023-00322-9 · Cited by 2
The impact of the Affordable Care Act Medicaid Expansion in Medicare beneficiaries with peripheral artery disease
Henkin, S., Kearing, S. A., Martínez‐Camblor, P., Zacharias, N., Creager, M. A., Young, M. N., Goodney, P. P., & Columbo, J. A. (2024) · Vascular Medicine · doi:10.1177/1358863x241237776 · Cited by 2
“35 Importantly, among Medicare beneficiaries undergoing major amputation for chronic limb-threatening ischemia, more than 60% did not undergo an angiogram or revascularization in a year preceding the amputation.”
Self-citation
Clinical considerations after endovascular therapy of peripheral artery disease
Giannopoulos, S., & Armstrong, E. J. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1914590 · Cited by 2
Antithrombotic Therapy After Peripheral Vascular Intervention
Hu, P. T., & Jones, S. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0706-0 · Cited by 3
Ways of decreasing incidence of complications in patients after endured reconstructive and endovascular operations on lower limb arteries
Аракелян, В. С. (2020) · Angiology and vascular surgery · doi:10.33529/angio2020106 · Cited by 2
Gaps in Dyslipidemia Care Among Working‐Aged Individuals With Employer‐Sponsored Health Care
Shiffman, D., Louie, J. Z., Devlin, J. J., Knowles, J. W., & McPhaul, M. J. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015807 · Cited by 2
Sensitivity and Specificity of Ankle Brachial Index (ABI) and Pulse Wave Handheld Doppler (PWHD) Compared with Angiography as Diagnostic Test for Patients with Peripheral Artery Disease (PAD)
Thomas, V., Tjandra, D., Sumangkut, R., Karundeng, B., & Korompis, G. (2021) · Journal of Indonesian Society for Vascular and Endovascular Surgery · doi:10.36864/jinasvs.2021.1.005 · Cited by 2
Mobile health technologies to improve walking distance in people with intermittent claudication
Elfghi, M., Dunne, D., Jones, J., Gibson, I., Flaherty, G. T., McEvoy, J. W., Sultan, S., Jordan, F., & Tawfick, W. A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014717 · Cited by 2
Effectiveness of debulking strategies in coronary and endovascular interventions: targets and tools
Todoran, T. M., Yourshaw, J. P., Powell, S. P., & Evans, M. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821451-0.00018-5 · Cited by 2
Peripheral Arterial Disease
Srivaratharajah, K., & Abramson, B. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819369-3.00017-4 · Cited by 2
Evaluation of the Effects of Extracorporeal Shockwave Therapy in Patients With Peripheral Arterial Disease: A Meta-Analysis of Randomized Control Trials
Munir, Z., Akash, M. S. H., Jaiprada, F., Tarboush, B. A., Ijaz, O., Bseiso, A., Palleti, S. K., & Amin, A. (2023) · Cureus · doi:10.7759/cureus.34729 · Cited by 2
Ischemic Heart Disease
Dasa, O., Smith, S. M., & Pepine, C. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00033-5 · Cited by 3
Prognostic effects of cardiovascular rehabilitation: facts and myths
Ordóñez, E. E., Conesa, D. R., & Vera, T. V. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04267-1 · Cited by 2
Maximizing the medical support, the first essential complementary treatment - controlling the infection, protecting the heart and the brain
Canale, M. P., Federici, M., & Cola, G. D. (2021) · Italian Journal of Vascular and Endovascular Surgery · doi:10.23736/s1824-4777.21.01492-3 · Cited by 2
Good Intentions, Unintended Consequences?
Beckman, J. A., & Kim, E. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.04.021 · Cited by 2
Self-citation
Cookbook Medicine Is the Recipe for Successfully Managing Patients With PAD
White, C. J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.034 · Cited by 2
“For PAD specifically, the NHANES (National Health and Nutrition Examination Survey) reported statins to be associated with a 65% reduction in all-cause mortality (6).”
Background
The Fate of Life and Limb After Peripheral Artery Revascularization
Olin, J. W., & Johnston‐Cox, H. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.021 · Cited by 2
Prevention and Management of Urgent/Emergent Limb Ischemia
McClure, G. R., Chan, N., Kaplovitch, E., Bhagirath, V. C., & Anand, S. S. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01472-9 · Cited by 2
The Possibility of ABI Screening in Japan
Miyata, T. (2022) · The Journal of Japanese College of Angiology · doi:10.7133/jca.22-00004 · Cited by 1
International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia
Strong, M. B., Farber, A. M., Armstrong, D. G., Azuma, N., Beckman, J. A., Bonaca, M. P., Bradbury, A. W., Conte, M. S., Fakorede, F. A., Goodney, P. P., et al. (2025) · British journal of surgery · doi:10.1093/bjs/znaf150 · Cited by 1
Self-citation
Prediction of all-cause mortality in endovascularly treated patients with peripheral arterial disease of the lower extremities
Pavlíková, V., Koščo, M., Hudák, M., Čery, J., Čeryová, B., & Rašiová, M. (2025) · Vascular · doi:10.1177/17085381251379804 · Cited by 1
“26 In our study group, 83.9% of all patients were treated with statins and 72.2% of patients were treated with ACE inhibitors/ARBs.”
Influential
Prognosis of Asymptomatic Peripheral Artery Disease Incidentally Detected on Abdominal Contrast Enhanced Computed Tomography: A Retrospective Single Centre Experience
Masuda, M., Kuroda, K., Fujimoto, W., Iwasaki, M., & Okuda, M. (2026) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2026.06.016 · Cited by 1
The Role of Endovascular Therapy in Peripheral Arterial Disease
Meltzer, A. J., & McKinsey, J. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_9 · Cited by 1
Tools for Cardiovascular Risk Assessment in Clinical Practice
Cainzos‐Achirica, M., Eissler, K., Blaha, M. J., Blumenthal, R. S., & Martin, S. S. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0455-4 · Cited by 2
Ticagrelor for the treatment of peripheral arterial disease
Chong, A., & So, D. Y. F. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.974803 · Cited by 1
Use of Health Care System-Supplied Aspirin by Veterans With Postoperative Heart Attack or Unstable Angina
Rivera, C. M., Copeland, L. A., McNeal, C. J., Mortensen, E. M., Pugh, M. J., & MacCarthy, D. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000560 · Cited by 1
Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities
Shishehbor, M. H., Aronow, H. D., Bartholomew, J. R., Beckman, J. A., Froehlich, J. B., Lookstein, R., Misra, S., Roberts, A. C., Rosenfield, K., & Jaff, M. R. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26512 · Cited by 1
Self-citation
Effects of additional exercise therapy after a successful vascular intervention for patients with symptomatic peripheral arterial disease
Cucato, G. G., Perren, D., Ritti‐Dias, R. M., & Saxton, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014736 · Cited by 1
Peripheral Artery Disease
Pande, R. L., & Creager, M. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00148-7 · Cited by 2
Self-citation
Hypertension Management in Peripheral Artery Disease: A Mini Review
Kharawala, A., Nagraj, S., Pargaonkar, S., Seo, J., Kokkinidis, D. G., & Altin, S. E. (2023) · Current Hypertension Reviews · doi:10.2174/0115734021267004231122061712 · Cited by 1
Association of antiplatelet therapy with clinical outcomes in patients with peripheral artery disease
Al‐Sadawi, M., Tao, M., Dhaliwal, S., Masson, R., Bhagat, A. A., Parikh, P. B., Lawson, W. E., & Reilly, J. P. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.12.013 · Cited by 1
Epidemiology of peripheral artery disease
Salameh, M., & Matsushita, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13593-4.00002-0 · Cited by 2
Millimeter wave radiation to measure blood flow in healthy human subjects
Nelson, J. L., Cobb, C., Keller, J. L., Traylor, M. K., Nelson, D. A., & Francis, C. M. (2024) · Physiological Measurement · doi:10.1088/1361-6579/ad7931 · Cited by 1
“At 5 years, approximately 20% of PAD patients will experience a nonfatal cardiovascular event, and 15%–20% of PAD patients will die, typically from cardiovascular causes (Criqui et al 1992, Pande et al 2011).”
Peripheral Artery Disease
Beckman, J. A., & Creager, M. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00018-5 · Cited by 1
Self-citation
ABI: The goal line is in sight
Beckman, J. A. (2018) · Vascular Medicine · doi:10.1177/1358863x17749300 · Cited by 1
Self-citation
Peripheral Artery Disease
Perlstein, T. S., & Krichavsky, M. Z. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00035-7 · Cited by 1
Self-citation
Conocimiento del cardiólogo sobre el fisioterapeuta y retos al remitir pacientes con enfermedad arterial periférica en Puerto Rico
Correa-Vázquez, E. J., de Jesús-Sosa, M. A., Reyes-Claudio, K. M., & Chévere-Rivera, K. (2019) · Fisioterapia · doi:10.1016/j.ft.2019.02.001 · Cited by 1
Antiplatelet Drugs in the Management of Thrombotic/Ischemic Events in Peripheral Artery Disease
Basili, S., & Violi, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00058-8 · Cited by 1
Epidemiology of Peripheral Arterial Diseases in Individuals with Diabetes Mellitus
Koo, B. K. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.1.10 · Cited by 1
Extracorporeal shockwave therapy for peripheral arterial disease
Fan, W., Yang, B., Liang, N., & Liang, S.-B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013509 · Cited by 1
Interventions for motor rehabilitation in patients with below-knee amputation due to peripheral arterial disease or diabetes
Aledi, L. B., Flumignan, C. D. Q., Neto, H. J. G., Trevisani, V. F. M., & Miranda, F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013711 · Cited by 1
Peripheral Vascular Disease in Circulation and the Circulation Subspecialty Journals
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.108464 · Cited by 1
Peripheral Arterial Diseases and Diabetes Mellitus: Associations With Quality of Health Measures in Patients Undergoing Percutaneous Vascular Interventions
Haque, M. Z., Reesha, S., Khan, S., Rafique, R., Saleem, A., Ilyas, O., Abdullah, L. C., Hussain, A., & Husain, M. (2022) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2022.11.003 · Cited by 1
Management of Peripheral Arterial Disease
Schernthaner, R. E., Schernthaner, G.-H., & Schernthaner, G. (2014) · Wiley eBooks · doi:10.1002/9781118337967.ch11 · Cited by 1
Artériopathie des membres inférieurs
Pande, R. L., Perlstein, T. S., Beckman, J. A., & Creager, M. A. (2012) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(12)70324-3 · Cited by 1
Self-citation
Peripheral artery disease
Beckman, J. A. (2002) · Handbook of Outpatient Cardiology · doi:10.1002/9781118618189.ch1 · Cited by 128
Self-citation
El índice tobillo-brazo como técnica de cribado: ¿promesa o realidad?
Manzano, L. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.10.004
Risikofaktoren für pAVK
Hoke, M. (2014) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-014-0066-x
PAD and claudication: Thinking outside the hemodynamics box
Pande, R. L. (2012) · Vascular Medicine · doi:10.1177/1358863x12437600
Self-citation
Vascular Specialist Response to Medicare Evidence Development Coverage Advisory Committee (MEDCAC) Panel on Peripheral Artery Disease of the Lower Extremities
Shishehbor, M. H., Aronow, H. D., Bartholomew, J. R., Beckman, J. A., Froehlich, J. B., Lookstein, R., Misra, S., Roberts, A. C., Rosenfield, K., & Jaff, M. R. (2016) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2016.03.008
Self-citation
Chronic lower limb peripheral arterial disease
Forsyth, J. M. (2015) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738015592043
Making a Difference for Patients with Peripheral Artery Disease by Advocating Together as One
Matsumoto, A. H., Angle, J. F., Benenati, J. F., Wiechmann, B. N., Marx, M. V., & Haskal, Z. J. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2016.04.020
Facteurs de risque de l’artériopathie athéromateuse des membres inférieurs
Cazaubon, M. (2016) · doi:10.1016/s2211-0364(16)66741-9
Role of Omega-3 Fatty Acid in Major Cardiovascular Events—A Current View
Wen, Y., & Gao, Q. (2016) · Springer eBooks · doi:10.1007/978-3-319-40458-5_25
Risk Factors for Peripheral Artery Disease in Patients With Ischemic Stroke or Transient Ischemic Attack
Kim, Y., Yu, K. H., Oh, M. S., Il, H., Kim, Y. K., Do, J., Park, H., & Lee, B. C. (2012) · Journal of the Korean Neurological Association
Hypertension in Ischemic Heart Disease
Smith, S. M., & Pepine, C. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00031-7
Medical Therapy of Peripheral Artery Disease
Joseph, L., & Kim, E. (2017) · Wiley eBooks · doi:10.1002/9781118775998.ch6
The role of dietary fatty acids from plant-based oils in metabolic and vascular disease
Enns, J. E. (2012) · Mspace (University of Manitoba)
Variation in High-Intensity Statin Use After Hospitalization for Acute Vascular Emergencies
Shanbhag, A., Ananthula, A., Palagiri, R. D. R., Parikh, R., Purushothaman, R., & Vallurupalli, S. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.05.006
Epidemiology, risk factors & prognosis
Hawkins, B. M., & Jaff, M. R. (2013) · doi:10.2217/ebo.12.149
Blood flow modelling in arteries with deformable walls
Siogkas, P. K. (2018) · doi:10.12681/eadd/43783
MR Plaque Imaging in Peripheral Artery Disease
Sun, J., & Yuan, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-24596-2_10
The enigma to best screen, evaluate and diagnose peripheral artery disease
Seinost, G., Höbaus, C., & Schernthaner, G.-H. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.007
Non-pharmaceutical alternatives or adjuncts to exercise programmes for people with intermittent claudication
Harwood, A. E., Pymer, S., Ibeggazene, S., Parmenter, B. J., & Chetter, I. C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014677
Risk factors and pharmacological therapy in patients with vascular disease
Maiolino, G., Rossato, M., & Vettor, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822113-6.00021-8
Antithrombotics after infra-inguinal bypass grafting
Thomas, M., Dawkins, C., & Shelmerdine, L. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015141
Antithrombotics after infra-inguinal peripheral endovascular treatment
Thomas, M., Gatmaitan, R., Saricilar, E. C., Patel, K., Ghouri, M. A., Kovacs, F., & Puttaswamy, V. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015142
Key aspects of drug therapy in vascular surgery
Аракелян, В. С. (2021) · Angiology and vascular surgery · doi:10.33529/angio2021401
8th Asian PAD Workshop
(2017) · Annals of Vascular Diseases · doi:10.3400/avd.pad.17-01000
Circulation Editors’ Picks
Editors, T. (2013) · Circulation · doi:10.1161/circulationaha.113.007431
Diet and Nutrition in Circulation and the Circulation Subspecialty Journals
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.105593
Most Important Papers in Peripheral Arterial Disease
Editors, T. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.971275
Circulation Editors' Picks
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.135517
Prevention in Circulation and the Circulation Subspecialty Journals
Editors, T. (2012) · Circulation · doi:10.1161/circulationaha.112.110163
Circulation Editors’ Picks
Editors, T. (2013) · Circulation · doi:10.1161/circulationaha.113.005495
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery Disease: Reply
Liu, Y., Chang, L., Wu, M., Xu, B., & Kang, L. (2022) · Angiology · doi:10.1177/00033197221128543
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery Disease: Reply
Liu, Y., Chang, L., Wu, M., Xu, B., & Kang, L. (2022) · Angiology · doi:10.1177/00033197221133941
Cessação do tabagismo para doença arterial periférica: protocolo de revisão sistemática
Kuramoto, D. A. B., ZANIN, L. F. S., Flumignan, R. L., Flumignan, C. D. Q., REICHER, M. E., Correia, R. M., & Nakano, L. C. U. (2023) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20233482
Epidemiology of Peripheral Vascular Disease
Wheeler, S., & Boyko, E. J. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_22
Exercise improves the treatment of peripheral arterial disease in extremely old patientsPreprint
Liu, X., Zhou, J., Wang, B., Zhou, L., Zhou, R., & Yang, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2960508/v1
Arterielle Durchblutungsstörungen – Begutachtung
Fritze, J. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61937-7_59-1
Medical therapy of PAD
Walker, M., & Beckman, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13593-4.00008-1
Self-citation
Statin Usage in Peripheral Arterial Disease Patients
Agrawal, S., Batta, S. A., Kamath, D. Y., Thomas, G. A., Boregowda, P., Adhyapak, S. M., & Varghese, K. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0522
Improvement in Optimal Discharge Medications Within the Vascular Quality Initiative is Associated with Improved Long-term Survival
Vaddavalli, V. V., Hanson, K. T., Chang, Y., & DeMartino, R. R. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.06.092
Evaluating Receipt of Optimal Medical Therapy Among Structurally Disadvantaged Groups Undergoing Amputation
Mize, B. M., Saati, A., Donzo, M. W., Forrester, N., Mustapha, A. F., Neill, A., Duwayri, Y. M., Massarweh, N. N., Akintobi, T. H., Patzer, R. E., et al. (2024) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2024.08.006
Primary care physicians’ diagnosis and management of vascular pathologies
Julia-Rios, N. M., Ortiz-Fullana, J. L., & Santini-Domínguez, R. (2024) · JVS-Vascular Insights · doi:10.1016/j.jvsvi.2024.100168
Arterielle Durchblutungsstörungen
Fritze, J. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-60980-4_59
Factors associated with severe lower extremity artery disease in type 2 diabetes based on a large scale claims database in Japan
Horii, T., Kawaguchi, M., Ikegami, Y., Oikawa, Y., Shimada, A., & Mihara, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-03797-9
Contemporary Health Disparities in the Diagnosis and Management of Claudication
Kernodle, A., Arinze, N. V., Mize, B. M., & Alabi, O. (2025) · Springer eBooks · doi:10.1007/978-3-032-02460-2_6
A Framework for Physicians and Patients with Claudication: Toward a Patient-Centered Approach
Simons, J. P., & Robinson, W. P., III (2025) · Springer eBooks · doi:10.1007/978-3-032-02460-2_1
Peripheral Arterial Disease: An Epidemiological Perspective
Kavousi, M. (2026) · Springer eBooks · doi:10.1007/978-3-031-82232-2_28
Asymptomatic Peripheral Arterial Disease and Intermittent Claudication: An Overview
Paciullo, F., Gresele, P., Parmar, G. M., & Catalano, M. M. (2026) · Springer eBooks · doi:10.1007/978-3-031-82232-2_29
We Must Embrace Peripheral Artery Disease: A Trainee Perspective
Shinagawa, A., Gutti, S., & Bhatt, A. B. (2026) · Techniques in vascular and interventional radiology · doi:10.1016/j.tvir.2026.101107
Three-Year Outcomes of the Auryon Laser Atherectomy System in Treating Infrainguinal Peripheral Arterial Disease: A Single-Center Experience
Shammas, N. W., Shammas, G. A., Tannenbaum, Y., Abbott, A., Bahia, A., Jones-Miller, S., & Shankarraman, V. (2026) · International Journal of Angiology · doi:10.1055/a-2836-0143
Marqueurs non-invasifs de stéatose et fibrose hépatique
Perazzo, H. (2014) · theses.fr (ABES) · doi:10.70675/02aba680z77b0z4903z96b9zce1c22dcaa83
Peripheral Artery Disease Prevalence: Scoping Review with ☸SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsaraec430229
Associations between estimated glucose disposal rate and peripheral artery disease: evidence from the UK Biobank and NHANES
Zeng, J., Zeng, X., Lin, W., Lin, X., Hu, F., Fan, L., Yu, C., & Chen, L. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01149-6
Concordance and overlap between peripheral artery disease and peripheral sensory neuropathy in diabetes
Amoako, J. K. A., Kottoh, E., Kwabena-Adade, E. N. A. O., Aikins-Ennin, E., Tenkorang, P. O., Nuakoh, P., Tetteh, G. A., Honyenuga, P. J., Boakye, S. A., Bannerman-Williams, E., et al. (2026) · Global Neurological Insights · doi:10.1016/j.gni.2026.100009
Punch skin grafting for patients with no-option for revascularisation chronic limb-threatening ischaemia: A case series
Masó-Albareda, C., Ferrer-Solà, M., Casals-Zorita, M., Palacio‐Arronis, N., Espaulella‐Panicot, J., & Otero-Viñas, M. (2026) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2026.06.001

Authors: Pande, R. L., Perlstein, T. S., Beckman, J. A., & Creager, M. A.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Pande, Reena L.
Beckman, Joshua A.
Creager, Mark A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-07-05
Volume: 124
Issue: 1
Pages: 17-23
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.110.003954
PMC: PMC3139992
OpenAlex: W2082336558
Semantic Scholar: 91f0b40eb962eac5bce27896ae06727a10351d5f
Cited by: 406
References: 30
Citations by year: 2026: 13 · 2025: 13 · 2024: 28 · 2023: 31 · 2022: 24 · 2021: 39 · 2020: 33 · 2019: 26 · 2018: 35 · 2017: 26 · 2016: 38 · 2015: 25 · 2014: 21 · 2013: 19 · 2012: 35
FWCI: 24.58
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (K12HL083786, R01HL075771)
Topics: Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
Keywords: peripheral arterial disease, secondary prevention, all-cause mortality, ankle-brachial index, statin use, ACE inhibitors, angiotensin receptor blockers, aspirin, cardiovascular risk reduction, untreated patients
MeSH terms: Aged, Angiotensin-Converting Enzyme Inhibitors, Aspirin, Cardiovascular Diseases, Female, Humans, Male, Nutrition Surveys, Retrospective Studies, Risk Factors, United States, Prevalence, Secondary Prevention, Angiotensin II Type 2 Receptor Blockers, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks